Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene

by Azam Ghafoor, MD, Idrees Mian, MD, Cathy Wagner, BSN, Yvonne Mallory, BSN, Maria Garcia Agra, BSN, Betsy Morrow, BS, Jun S. Wei, PhD, Javed Khan, MD, Anish Thomas, M.B.B.S., MD, Manjistha Sengupta, PhD, Seth M. Steinberg, PhD, Raffit Hassan, MD
Published 2021-10-01